INSYS Therapeutics Inc (INSY.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|61||2017||Independent Chairman of the Board|
|51||2017||President, Chief Executive Officer, Director|
|2017||Chief Financial Officer|
|Senior Vice President - Research & Development|
|Senior Vice President - Regulatory Affairs|
- BRIEF-Insys Therapeutics To Advance Clinical Research Of Dronabinol Inhalation Using Novel Breath-Actuated Device
- BRIEF-Insys Therapeutics Appoints Trudy Vanhove To Board Of Directors
- BRIEF-Insys Says Working With Authorities To Resolve Issues Related To "Inappropriate Actions" Taken By Former Employees
- UPDATE 3-Five New York doctors charged with taking kickbacks from Insys
- Five New York doctors charged with taking kickbacks from Insys